Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DUO-O: A randomized phase Ill trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients
    Meeting Abstract

    Harter, P.; Bidziński, M.; Colombo, N.; Floquet, A.; Pérez, M. J. R.; Kim, J. W.; Lheureux, S.; Marth, C.; Nyvang, G. B.; Okamoto, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world effectiveness of approved anticancer agents among Medicare beneficiaries
    Meeting Abstract

    Green, A.; Curry, M. A.; Bach, P.; Mailankody, S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of maintenance olaparib for newly diagnosed, advanced ovarian cancer patients (pts) by BRCA1 or BRCA2 mutation in the phase III SOLO1 trial
    Meeting Abstract

    Friedlander, M.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Factors associated with one-year mortality after debulking surgery in older women with ovarian cancer
    Meeting Abstract

    Filippova, O. T.; Tew, W. P.; O'Cearbhaill, R. E.; Sonoda, Y.; Long-Roche, K. C.; Zivanovic, O.; Gardner, G. J.; Chi, D.; Shahrokni, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry
    Meeting Abstract

    Duruisseaux, M.; Liu, S. V.; Han, J. Y.; Gounant, V.; Shih, J. Y.; Schram, A. M.; Schrock, A. B.; Ali, S. M.; Magne, F.; Monnet, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk stratification and daily symptom monitoring for oncology patients
    Meeting Abstract

    Daly, R. M.; Perry, C.; Chiu, Y. O.; Katzen, L. L.; Rozenshteyn, M.; Kuperman, G.; Dhami, A. K.; Salvaggio, R.; Baldwin, A.; Holland, J. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adverse events (AEs) with maintenance olaparib in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Phase III SOLO1 trial
    Meeting Abstract

    Colombo, N.; Moore, K. N.; Scambia, G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Exploratory analysis of the effect of maintenance rucaparib on postprogression outcomes in patients (pts) with platinum-sensitive recurrent ovarian carcinoma (OC) and updated safety data from the phase 3 study ARIEL3
    Meeting Abstract

    Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC)
    Meeting Abstract

    Cadoo, K. A.; Meyers, M. L.; Burger, R. A.; Armstrong, D. K.; Penson, R. T.; Gordon, M. S.; Fleming, G. F.; Moroney, J. W.; Hamilton, E. P.; Duska, L. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save